Health
FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation – News-Medical.Net
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity—or hand, wrist and arm—disability.
Thousands of stroke survivors…
-
Business15 hours agoWarning! These ASX 200 shares were just downgraded
-
Business13 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General23 hours agoSergio Perez and Valtteri Bottas to return to Formula 1 with Cadillac
-
General11 hours agoIndian exporters brace for introduction of US tariffs topping 50 per cent from today